The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer
Open accessAbstract
Background: Malignant brain cancer persists as a major disease of morbidity and mortality in adults and is the second leading cause of cancer death in children. Many current therapies for malignant brain tumors fail to provide long-term management because they ineffectively target tumor cells while negatively impacting the health and vitality of normal brain cells. In contrast to brain tumor cells, which lack metabolic flexibility and are largely dependent on glucose for growth and survival, normal brain cells can metabolize both glucose and ketone bodies for energy. This study evaluated the efficacy of KetoCal®, a new nutritionally balanced high fat/low carbohydrate ketogenic diet for children with epilepsy, on the growth and vascularity of a malignant mouse astrocytoma (CT-2A) and a human malignant glioma (U87-MG). Methods: Adult mice were implanted orthotopically with the malignant brain tumors and KetoCal®was administered to the mice in either unrestricted amounts or in restricted amounts to reduce total caloric intake according to the manufacturers recommendation for children with refractory epilepsy. The effects KetoCal®on tumor growth, vascularity, and mouse survival were compared with that of an unrestricted high carbohydrate standard diet. Results: KetoCal®administered in restricted amounts significantly decreased the intracerebral growth of the CT-2A and U87-MG tumors by about 65% and 35%, respectively, and significantly enhanced health and survival relative to that of the control groups receiving the standard low fat/high carbohydrate diet. The restricted KetoCal®diet reduced plasma glucose levels while elevating plasma ketone body (β-hydroxybutyrate) levels. Tumor microvessel density was less in the calorically restricted KetoCal®groups than in the calorically unrestricted control groups. Moreover, gene expression for the mitochondrial enzymes, β-hydroxybutyrate dehydrogenase and succinyl-CoA: 3-ketoacid CoA transferase, was lower in the tumors than in the contralateral normal brain suggesting that these brain tumors have reduced ability to metabolize ketone bodies for energy. Conclusion: The results indicate that KetoCal®has anti-tumor and anti-angiogenic effects in experimental mouse and human brain tumors when administered in restricted amounts. The therapeutic effect of KetoCal®for brain cancer management was due largely to the reduction of total caloric content, which reduces circulating glucose required for rapid tumor growth. A dependency on glucose for energy together with defects in ketone body metabolism largely account for why the brain tumors grow minimally on either a ketogenic-restricted diet or on a standard-restricted diet. Genes for ketone body metabolism should be useful for screening brain tumors that could be targeted with calorically restricted high fat/low carbohydrate ketogenic diets. This preclinical study indicates that restricted KetoCal®is a safe and effective diet therapy and should be considered as an alternative therapeutic option for malignant brain cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 2×
“Our gene expression results in the mouse CT-2A and the human U87 brain tumors are consistent with these previous findings in other tumors and also support the mitochondrial defect theory of cancer [5,23,24,69].”
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Determination of subcutaneous tumor size in athymic (nude) mice
Tomayko, M. M., & Reynolds, C. P. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00300234 · Cited by 1,830 · cited 1×
“Calipers were used to measure tumor volume as previously described [46].”
Enzymic determination of d(−)-β-hydroxybutyric acid and acetoacetic acid in blood
WILLIAMSON, D., MELLANBY, J., & KREBS, H. (1962) · Biochemical Journal · doi:10.1042/bj0820090 · Cited by 1,397
Biology of the Laboratory Mouse
HESTON, W. E. (1967) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a107528 · Cited by 1,394
Biology of the Laboratory Mouse
(1941) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1941.02820440081034 · Cited by 802
Veech, R. L. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.09.007 · Cited by 755
LONG TERM CULTURE OF NORMAL AND NEOPLASTIC HUMAN GLIA
PONTÉN, J., & MACINTYRE, E. H. (1968) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1968.tb03502.x · Cited by 720
d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 535
Ketone Bodies, Potential Therapeutic Uses
Veech, R. L., Chance, B., Kashiwaya, Y., Lardy, H. A., & Cahill, G. F. (2001) · IUBMB Life · doi:10.1080/152165401753311780 · Cited by 429
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
Malik, A., Afaq, F., Sarfaraz, S., Adhami, V. M., Syed, D. N., & Mukhtar, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505870102 · Cited by 401 · cited 1×
“Survival was determined as the time for subcutaneous tumors to reach the size of 2.5 cm3 after tumor inoculation as previously described [ 45 ].”
InfluentialEarly‐ and Late‐onset Complications of the Ketogenic Diet for Intractable Epilepsy
Kang, H. C., Chung, D. E., Kim, D. W., & Kim, H. D. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.10004.x · Cited by 390
Bowers, D. C., Liu, Y., Leisenring, W., McNeil, E., Stovall, M., Gurney, J. G., Robison, L. L., Packer, R. J., & Oeffinger, K. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2884 · Cited by 383
Shirlaw, J. T. (1931) · BMJ · doi:10.1136/bmj.1.3653.74-a · Cited by 363
Low-glycemic-index treatment: A liberalized ketogenic diet for treatment of intractable epilepsy
Pfeifer, H. H., & Thiele, E. A. (2005) · Neurology · doi:10.1212/01.wnl.0000187071.24292.9e · Cited by 346
Nebeling, L. C., Miraldi, F., Shurin, S. B., & Lerner, E. (1995) · Journal of the American College of Nutrition · doi:10.1080/07315724.1995.10718495 · Cited by 311
Population-based epidemiologic data on brain tumors in German children
Kaatsch, P., Rickert, C. H., K�hl, J., Sch�z, J., & Michaelis, J. (2001) · Cancer · doi:10.1002/1097-0142(20011215)92:12<3155::aid-cncr10158>3.0.co;2-c · Cited by 309
Cerebral ketone body metabolism
Morris, A. A. M. (2005) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-5518-0 · Cited by 298
Role of glucose and ketone bodies in the metabolic control of experimental brain cancer
Seyfried, T. N., Sanderson, T. M., El-Abbadi, M. M., McGowan, R., & Mukherjee, P. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601269 · Cited by 267
Self-citationTHE INFLUENCE OF DIET ON TRANSPLANTED AND SPONTANEOUS MOUSE TUMORS
Rous, P. (1914) · Journal of Experimental Medicine · doi:10.1084/jem.20.5.433 · Cited by 259
Cahill, G. F., & Veech, R. L. (2003) · PubMed · Cited by 246
Mukherjee, P., Sotnikov, A. V., Mangian, H. J., Zhou, J.-R., Visek, W. J., & Clinton, S. K. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.512 · Cited by 237
Self-citationTargeting energy metabolism in brain cancer: review and hypothesis
Seyfried, T. N., & Mukherjee, P. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-30 · Cited by 224
Self-citationProfile of Daily Life in Children With Brain Tumors: An Assessment of Health-Related Quality of Life
Bhat, S. R., Goodwin, T. L., Burwinkle, T. M., Lansdale, M. F., Dahl, G. V., Huhn, S. L., Gibbs, I. C., Donaldson, S. S., Rosenblum, R. K., Varni, J. W., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.190 · Cited by 214
Caloric Restriction Inhibits Seizure Susceptibility in Epileptic EL Mice by Reducing Blood Glucose
Greene, A. E., Todorova, M. T., McGowan, R., & Seyfried, T. N. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.17601.x · Cited by 196
Self-citationKetones: Metabolism's Ugly Duckling
Vanitallie, T. B., & Nufert, T. H. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.oct.327-341 · Cited by 191
Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model
Mukherjee, P., El-Abbadi, M. M., Kasperzyk, J. L., Ranes, M. K., & Seyfried, T. N. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600298 · Cited by 178
Self-citationHow to report statistics in medicine
Lang, T., & Secic, M. (2017) · Journal of Neurology & Neurophysiology · Cited by 171
Ketone body synthesis in the brain: possible neuroprotective effects
Guzmán, M., & Blázquez, C. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.05.001 · Cited by 170
Mukherjee, P., Abate, L. E., & Seyfried, T. N. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0308 · Cited by 169
Self-citationGreene, A. E., Todorova, M. T., & Seyfried, T. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01862.x · Cited by 168
Self-citationTrends in incidence of primary brain tumors in the United States, 1985-1994
Jukich, P. J., McCarthy, B. J., Surawicz, T. S., Freels, S. A., & Davis, F. G. (2001) · Neuro-Oncology · doi:10.1093/neuonc/3.3.141 · Cited by 145
Reduction of weight loss and tumour size in a cachexia model by a high fat diet
Tisdale, M. J., Brennan, R. A., & Fearon, K. C. H. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.149 · Cited by 134
Lowry, J. K., Snyder, J. J., & Lowry, P. W. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.922 · Cited by 132
The glucocorticoid paradox of caloric restriction in slowing brain aging
PATEL, N., & Finch, C. E. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00017-9 · Cited by 127
The role of ketone bodies in caloric homeostasis
Krebs, H. A., Williamson, D., Bates, M. W., Page, M. A., & Hawkins, R. A. (1971) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(71)80055-9 · Cited by 125
Ganglioside distribution in murine neural tumors
Seyfried, T. N., El‐Abbadi, M. M., & Roy, M. L. (1992) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159989 · Cited by 124
Self-citationEffects of the ketogenic diet in the glucose transporter 1 deficiency syndrome
Klepper, J., Diefenbach, S., Kohlschütter, A., & Voït, T. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.07.004 · Cited by 120
The Ketogenic Diet Inhibits Epileptogenesis in EL Mice: A Genetic Model for Idiopathic Epilepsy
Todorova, M. T., Tandon, P., Madore, R. A., Stafstrom, C. E., & Seyfried, T. N. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00275.x · Cited by 119
Self-citationOudard, S. M., Boitier, E., Miccoli, L., Rousset, S., Dutrillaux, B., & Poupon, M. (1997) · PubMed · Cited by 116
Ketonic Diet in the Management of Pyruvate Dehydrogenase Deficiency
Falk, R. E., Cederbaum, S. D., Blass, J. P., et al. (1976) · PEDIATRICS · doi:10.1542/peds.58.5.713 · Cited by 113
Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans
Mahoney, L. B., Denny, C. A., & Seyfried, T. N. (2006) · Lipids in Health and Disease · doi:10.1186/1476-511x-5-13 · Cited by 110
Self-citationMantis, J. G., Centeno, N. A., Todorova, M. T., McGowan, R., & Seyfried, T. N. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-11 · Cited by 108
Self-citationTHE INHIBITION OF MALIGNANT CELL GROWTH BY KETONE BODIES
Magee, B. A., Potezny, N., Rofe, A. M., & Conyers, R. A. J. (1979) · Immunology and Cell Biology · doi:10.1038/icb.1979.54 · Cited by 101
D‐β‐hydroxybutyrate protects dopaminergic SH‐SY5Y cells in a rotenone model of Parkinson's disease
Imamura, K., Takeshima, T., Kashiwaya, Y., Nakaso, K., & Nakashima, K. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21021 · Cited by 101
Anti-Inflammatory Mechanisms of Dietary Restriction in Slowing Aging Processes
Morgan, T. E., Wong, A., & Finch, C. E. (2006) · KARGER eBooks · doi:10.1159/000096557 · Cited by 100
The Ketogenic Diet: An Effective Medical Therapy With Side Effects
Wheless, J. W. (2001) · Journal of Child Neurology · doi:10.1177/088307380101600901 · Cited by 99
Taylor, M. R., Hurley, J. B., Epps, H. A. V., & Brockerhoff, S. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307074101 · Cited by 97
Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues
Tisdale, M. J., & Brennan, R. A. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.38 · Cited by 91
Nebeling, L. C., & Lerner, E. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00189-1 · Cited by 90
D ‐β‐hydroxybutyrate is neuroprotective against hypoxia in serum‐free hippocampal primary cultures
Masuda, R., Monahan, J. W., & Kashiwaya, Y. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20464 · Cited by 80
Malignant Gliomas in 2005: Where to GO From Here?
Fisher, P. G., & Buffler, P. A. (2005) · JAMA · doi:10.1001/jama.293.5.615 · Cited by 76
The Ketogenic Diet: A Treatment for Epilepsy
Freeman, J. M., Freeman, J. B., & Kelly, M. T. (2000) · Medical Entomology and Zoology · Cited by 70
Ketogenic diet reduces hypoglycemia-induced neuronal death in young rats
Yamada, K. A., Rensing, N. R., & Thio, L. L. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.05.038 · Cited by 70
Enhanced Aspartate Release from Hippocampal Slices of Epileptic (El) Mice
Flavin, H. J., Wieraszko, A., & Seyfried, T. N. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02021.x · Cited by 69
Self-citationHow to Report Statistics in Medicine
(1997) · Nature Medicine · doi:10.1038/nm0697-692 · Cited by 62
3‐Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system1
Fredericks, M. R., & Ramsey, R. B. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb06581.x · Cited by 60
John, A. P. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1335 · Cited by 53
Stewart, J. W., Koehler, K., Jackson, W. J., Hawley, J., Wang, W., Au, A., Myers, R. E., & Birt, D. F. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi051 · Cited by 45
N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours
Ranes, M. K., El‐Abbadi, M. M., Manfredi, M. G., Mukherjee, P., Platt, F. M., & Seyfried, T. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1713 · Cited by 44
Self-citationGrowth Failure After Treatment of Pediatric Brain Tumors
Clarson, C. L., & Maestro, R. F. D. (1999) · PEDIATRICS · doi:10.1542/peds.103.3.e37 · Cited by 42
Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer?
Mavropoulos, J. C., Isaacs, W. B., Pizzo, S. V., & Freedland, S. J. (2006) · Urology · doi:10.1016/j.urology.2006.03.073 · Cited by 39
Zhu, Z., Jiang, W., & Thompson, H. J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg077 · Cited by 39
Ketone-body metabolism in tumour-bearing rats
Rofe, A. M., Bais, R., & Conyers, R. A. J. (1986) · Biochemical Journal · doi:10.1042/bj2330485 · Cited by 35
Abate, L. E., Mukherjee, P., & Seyfried, T. N. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04097.x · Cited by 31
Self-citationExpression of Mouse Sialic Acid on Gangliosides of a Human Glioma Grown as a Xenograft in SCID Mice
Ecsedy, J., Holthaus, K. A., Yohe, H. C., & Seyfried, T. N. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730254.x · Cited by 29
Self-citationSawai, M., Yashiro, M., Nishiguchi, Y., Ohira, M., & Hirakawa, K. (2004) · PubMed · Cited by 24
Diet therapy in refractory pediatric epilepsy: increased efficacy and tolerability
Kang, H., & Kim, H. D. (2006) · Epileptic Disorders · doi:10.1684/j.1950-6945.2006.tb00284.x · Cited by 21
Seyfried, T. N., & Mukherjee, P. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_15 · Cited by 20
Self-citationBai, H., & Seyfried, T. N. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37285-0 · Cited by 18
Self-citation
Cited by
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Seyfried, T. N., & Shelton, L. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-7 · Cited by 644
Self-citationThe neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 574
Metadata
- Authors
- Zhou, W., Mukherjee, P., Kiebish, M. A., Markis, W. T., Mantis, J. G., & Seyfried, T. N.
- Venue
- Nutrition & Metabolism
- Published
- 2007-02-21
- Volume
- 4
- Issue
- 1
- Pages
- 5-5
- ISSN
- 1743-7075 (ISSN-L)
- OpenAlex
- W1606666119
- Cited by
- 299
- References
- 70
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.